Pitt Pharmacy Assistant Professor Kangho Suh, PharmD, PhD, received a subaward to develop cost-effectiveness models for the Institute of Clinical and Economic Review (ICER) in collaboration with Dr. Josh Carlson from University of Washington, as part of ICER’s drug assessment program.
Suh and Carlson will develop cost-effectiveness models for two topics (to be determined) for ICER in 2022. Reports include a full analysis of a drug’s comparative effectiveness, cost-effectiveness, and potential budget impact. ICER uses transparent methods to calculate for each new drug a value-based price benchmark anchored to the real benefits the drug brings to patients.
Suh is an Assistant Professor at the University of Pittsburgh School of Pharmacy, where he specializes in Health Economics & Outcomes Research within the Department of Pharmacy and Therapeutics. He joined the faculty in the fall of 2019.
